From Henry Jennings in the Marcus Today Newsletter:
Source: Marcus Today
- Mesoblast (MSB) – A great day yesterday after a deal with a Chinese Pharmaceutical. I got to chat with the CEO Silviu Iteschu on Sky Business. Always good to be able to ask questions to a CEO. I asked him if we would see far more of these style deals rather than the expensive funding and financing deals we have seen in the past. He said yes. He was also at pains to stress that the funding they had put in place was non-dilutive and was payable out of sales down the track. The stock eased a little in the US last night to a 177c equivalent so maybe we will see some consolidation but this deal with Tasly yesterday is a significant step in the right direction. We continue to hold. We would expect to see 200c in the next week or so as brokers look at the deal more closely.
Cheers.
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly, page-180
-
- There are more pages in this discussion • 113 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |